Cannabis has undergone a dramatic shift in public perception over the past several decades. During the 1980s and 1990s, marijuana was heavily stigmatized, largely framed as a dangerous “gateway drug” that threatened social stability. Punishments in many parts of the world were severe, and public discourse emphasized moral and criminal risks rather than medical or recreational potential. Over time, however, attitudes in the United States have changed significantly, with 24 states now permitting recreational use and even more allowing medical marijuana. Support for legalization has steadily grown, reflecting broader cultural acceptance and the possibility of cannabis becoming a regulated, normalized substance similar to alcohol.
Despite growing acceptance, cannabis is not without risk. The primary psychoactive component, THC, produces a variety of effects, including relaxation, euphoria, altered perception, and increased appetite. However, some users experience negative reactions such as anxiety, paranoia, or rapid heart rate, and in rare cases, heavy consumption has been linked to psychosis, particularly in individuals with predisposed mental health vulnerabilities. These effects illustrate that normalization and legal access do not imply harmlessness, and users must remain aware of potential physical and psychological consequences.
A particularly concerning condition associated with cannabis use is Cannabis Hyperemesis Syndrome (CHS). Increasingly reported in emergency rooms across the U.S., CHS causes severe nausea, uncontrollable vomiting, and extreme abdominal pain, sometimes described as “scromiting” — a term blending screaming and vomiting due to the intensity of suffering. Episodes typically occur within 24 hours of cannabis use and may last for several days. Traditional anti-nausea treatments often fail, and sufferers frequently resort to hot showers to relieve symptoms, a behavior recognized as a hallmark of the syndrome.
CHS often presents cyclically, with repeated hospital visits for the same individuals. Patients describe agonizing pain sometimes requiring morphine and compare its intensity to childbirth. Medical experts emphasize that the only effective treatment is cessation of cannabis use, as symptoms can recur or worsen if consumption continues. Early and prolonged exposure to cannabis appears to increase the likelihood of developing CHS, highlighting the importance of recognizing patterns of heavy use, especially among vulnerable populations.
Alarmingly, adolescent cases of CHS have increased sharply, rising more than tenfold between 2016 and 2023. Interestingly, the fastest growth has occurred in states where recreational cannabis remains illegal, though overall case numbers tend to be higher in legalized states due to increased usage. Researchers point to factors such as product potency, youth access, and lack of education as potential contributors to this trend, emphasizing the need for public health interventions and informed awareness about the risks of modern, high-THC cannabis products.
The broader implications of CHS and cannabis use underscore the necessity of balancing acceptance with caution. While many users consume cannabis safely, the emergence of severe health conditions demonstrates that no substance is entirely without risk. Public health education must evolve alongside legalization, and consumers should be aware of both benefits and potential harms. Ultimately, as cultural attitudes shift and cannabis becomes more normalized, informed decision-making remains crucial to protecting individual and community health.
